Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

CSE:AGN - Post Discussion

Algernon Pharmaceuticals Inc. > Ifenprodil as a treatment for IPF approved by FDA

View:

Post by StockHawk1 on Dec 14, 2022 5:39pm

Ifenprodil as a treatment for IPF approved by FDA

Algernon Pharmaceuticals' (AGN.c AGNPF) filing to get Orphan Drug Designation for Ifenprodil as a treatment for Idiopathic Pulmonary Fibrosis (IPF) was recently approved by the US FDA.

The designation is mandatory for AGN to be able to commercialize its Ifenprodil treatment. So the approval means that AGN has passed a significant hurdle.

With the designation granted, AGN is planning the next steps for a clinical study of Ifenprodil for the treatment of IPF and chronic cough.

https://www.nxtlifescience.com/news-releases/cse-agn-algernon-pharmaceuticals-receives-u-s-fda-orphan-drug-designation-for-ifenprodil-for-the-treatment-of-idiopathic-pulmonary-fibrosis/#

213